| Octapharma AG - octaplasLG, Pulver und Lösungsmittel zur Herstellung einer Infusionslösung |
| 69780 | | 01 | | octaplasLG | | Pulver und Lösungsmittel zur Herstellung einer Infusionslösung | | B05AA | | Blutersatzmittel und Plasmaproteinfraktionen | | 12.11.2024 | | |
|
| Composition |
| Praeparatio cryodesiccata: proteina plasmatis humani 9-14 g, natrii citras dihydricus, natrii dihydrogenophosphas dihydricus, acidum citricum monohydricum, acidum phosphoricum, glycinum, pro vitro corresp. natrium <40 mmol.
Solvens: aqua ad iniectabile pro charta. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | Pulver und Lösungsmittel zur Herstellung einer Infusionslösung | | | | | | Principe actif | Concentr. |
|---|
| Proteina Plasmatis Humani | 9-14 g |
| | | | Agents auxilliaires |
|---|
| Acide Citrique Monohydre | | Acide Phosphorique | | Glycine | | Natrii Citras Dihydricus | | Sodium Dihydrogenophosphate Dihydrate |
|
| Solvens | | aqua ad iniectabile pro charta | | | |
| Solvens | | aqua ad iniectabile pro charta | | | |
| Solvens | | aqua ad iniectabile pro charta | | | |
| Solvens | | aqua ad iniectabile pro charta | | | |
| Solvens | | aqua ad iniectabile pro charta | | | |
| Solvens | | aqua ad iniectabile pro charta | | | |
| Solvens | | aqua ad iniectabile pro charta | | | |
| Solvens | | aqua ad iniectabile pro charta | | | |
| Solvens | | aqua ad iniectabile pro charta | | | |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | | | | B | | Oui | | 002 | | | | B | | Non | | 003 | | | | B | | Oui | | 004 | | | | B | | Oui |
|
